NUVL Q4 2024 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$86M

Net Income

-$75M

EPS (Diluted)

$-1.05

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$62M

Stock-Based Comp.

$16M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$72M

Stockholders' Equity

$1.1B

Cash & Equivalents

$146M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$86M	-$46M	-85.8%
Net Income	-$75M	-$38M	-95.2%